SCHEMBL8486398

SCHEMBL8486398

NC(=NO)c1ccccc1-c1nc(-c2ccc(F)cc2)c(-c2ccncc2)[nH]1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 8/20 0.69
MAPK14 Q16539 14/20 0.66
CSNK1D P48730 5/20 0.66
CSNK1E P49674 4/20 0.66
MAPK13 O15264 11/20 0.64
GCGR P47871 11/20 0.64
MAPK12 P53778 11/20 0.64
MAPK11 Q15759 11/20 0.64
BRAF P15056 2/20 0.61
PRKD3 O94806 2/20 0.58
MAP4K4 O95819 2/20 0.58
FRK P42685 2/20 0.58
MAPK9 P45984 2/20 0.58
CSNK1A1 P48729 2/20 0.58
GSK3B P49841 2/20 0.58
PTK6 Q13882 2/20 0.58
CLK4 Q9HAZ1 2/20 0.58
PRKD2 Q9BZL6 1/20 0.58
KDM4E B2RXH2 1/20 0.56
CIT O14578 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8484842 0.87 ALOX5 (0.69) ALOX5MAPK14CSNK1DCSNK1EMAPK13
SCHEMBL8484309 0.83 KDM4E (0.73) ALOX5MAPK14CSNK1DCSNK1EMAPK13
SCHEMBL5076167 0.82 ALOX5 (1.00) ALOX5MAPK14CSNK1DCSNK1EMAPK13
SCHEMBL8483911 0.80 ALOX5 (0.69) ALOX5MAPK14CSNK1DCSNK1EMAPK13
SCHEMBL4563107 0.80 ALOX5 (1.00) ALOX5MAPK14CSNK1DCSNK1EMAPK13
SCHEMBL17002225 0.80 MAPK14 (0.77) ALOX5MAPK14CSNK1DCSNK1EMAPK13
SCHEMBL17002317 0.80 MAPK14 (1.00) ALOX5MAPK14CSNK1DCSNK1EMAPK13
SCHEMBL30197605 0.80 MAPK14 (1.00) ALOX5MAPK14CSNK1DCSNK1EMAPK13
SCHEMBL6003680 0.78 MAPK14 (1.00) ALOX5MAPK14CSNK1DCSNK1EMAPK13
SCHEMBL6450700 0.78 MAPK14 (0.77) ALOX5MAPK14CSNK1DCSNK1EMAPK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5916891-A CYTOKINE MEDIATED DISEASES SMITHKLINE BEECHAM CORPORATION (US) 1999-06-29 US disclosed